Coverage of our work removing the barriers between a child with cancer and the care that could save their life — plus media contacts and organizational background for reporters.
Coverage of the partnership between Golden Thread, Mark Cuban Cost Plus Drug Company, and RxSaveCard to lower the cost of medications for pediatric cancer clinical trials and deliver them directly to patients’ homes.
Golden Thread’s co-founders are practicing pediatric neuro-oncologists. The coverage below reflects their clinical, academic, and research work at their respective institutions. It is included as context on the physician leadership behind Golden Thread and does not represent the positions of Golden Thread or of any institution named.
For interviews, background, or comment on pediatric cancer policy, drug access, and clinical trial infrastructure.
Golden Thread’s co-founders, Ashley Margol, MD, MS, and Cassie Kline, MD, MAS, speak on behalf of the organization. Requests regarding their clinical or institutional work should be directed to the media relations office at the relevant institution.
Golden Thread is a physician-led nonprofit working to remove the barriers that stand between a child with cancer and the care that could save their life. Co-founded by pediatric neuro-oncologists Ashley Margol, MD, MS, and Cassie Kline, MD, MAS, Golden Thread works across three pillars: modern policy, including interstate licensure reform; strategic matchmaking that brokers partnerships across a siloed field; and modern infrastructure that reduces the operational load of running pediatric cancer clinical trials.
Golden Thread is a registered 501(c)(3) nonprofit organization, EIN 39-2888795. Learn more at agoldenthread.org.